Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedJun 08, 2023
DataAggregated Company Financials
Companies26
  • 7D1.4%
  • 3M5.6%
  • 1Y-4.0%
  • YTD0.4%

Over the last 7 days, the Pharma industry has risen 2.7%, driven by gains from AstraZeneca of 2.9%. Despite this gain, the industry's performance has been flat over the past year. Looking forward, earnings are forecast to grow by 19% annually.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 08 Jun 2023UK£251.2bUK£68.6bUK£8.0b55.5x31.5x3.7x
Sat, 06 May 2023UK£258.0bUK£68.0bUK£7.9b57.3x32.6x3.8x
Mon, 03 Apr 2023UK£243.3bUK£69.5bUK£6.9b51.9x35.3x3.5x
Wed, 01 Mar 2023UK£238.7bUK£70.3bUK£7.0b53x33.9x3.4x
Fri, 27 Jan 2023UK£235.3bUK£79.1bUK£6.3b38.3x37.4x3x
Sun, 25 Dec 2022UK£245.2bUK£80.2bUK£6.3b37.7x38.7x3.1x
Tue, 22 Nov 2022UK£239.4bUK£81.1bUK£6.4b26.6x37.5x3x
Thu, 20 Oct 2022UK£218.1bUK£80.9bUK£3.7b20.4x59.6x2.7x
Sat, 17 Sep 2022UK£221.6bUK£80.2bUK£3.7b15.1x60.2x2.8x
Mon, 15 Aug 2022UK£237.6bUK£77.8bUK£3.8b14.9x63.2x3.1x
Wed, 13 Jul 2022UK£274.5bUK£75.5bUK£4.5b16.1x60.4x3.6x
Fri, 10 Jun 2022UK£254.9bUK£73.7bUK£4.6b16.4x55.7x3.5x
Sun, 08 May 2022UK£262.3bUK£74.1bUK£4.6b17.2x57.4x3.5x
Tue, 05 Apr 2022UK£256.6bUK£66.5bUK£4.8b19.8x53.4x3.9x
Thu, 03 Mar 2022UK£239.6bUK£66.1bUK£4.8b31.2x50.4x3.6x
Sat, 29 Jan 2022UK£235.8bUK£61.5bUK£5.6b31.9x41.8x3.8x
Mon, 27 Dec 2021UK£233.6bUK£61.6bUK£5.6b32.1x41.4x3.8x
Wed, 24 Nov 2021UK£227.2bUK£61.6bUK£5.7b31x40.2x3.7x
Fri, 22 Oct 2021UK£227.0bUK£58.1bUK£7.5b27.2x30.4x3.9x
Sun, 19 Sep 2021UK£215.7bUK£58.2bUK£7.5b29.4x28.7x3.7x
Tue, 17 Aug 2021UK£230.5bUK£58.1bUK£7.5b26.9x30.7x4x
Tue, 01 Jun 2021UK£190.4bUK£56.2bUK£8.5b26.8x22.4x3.4x
Fri, 05 Mar 2021UK£166.1bUK£57.2bUK£8.3b33.9x20.1x2.9x
Mon, 07 Dec 2020UK£186.6bUK£57.9bUK£8.4b41.7x22.1x3.2x
Thu, 10 Sep 2020UK£198.1bUK£59.5bUK£8.5b44.1x23.2x3.3x
Price to Earnings Ratio

24.1x


Total Market Cap: UK£205.7bTotal Earnings: UK£8.5bTotal Revenue: UK£59.5bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 37.8x202120222023
Current Industry PE
  • Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 31.7x which is lower than its 3-year average PE of 37.8x.
  • The industry is trading close to its 3-year average PS ratio of 3.5x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 2.3% per year over the last three years.
  • Meanwhile revenues for these companies have grown 4.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does U.K. Pharma compare with similar industries?

GB Market2.27%
Healthcare1.22%
Pharma1.39%
Pharma1.39%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AZN AstraZenecaUK£117.540.8%
+UK£1.5b
14.0%PE48.2x
GSK GSKUK£13.762.2%
+UK£1.2b
-37.1%PE12.5x
INDV IndiviorUK£17.1617.9%
+UK£359.9m
8.5%PS3.1x
DPH Dechra PharmaceuticalsUK£36.268.6%
+UK£325.7m
3.2%PE103x
HCM HUTCHMED (China)UK£2.003.5%
+UK£57.6m
8.7%PS4.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GSK

UK£13.76

GSK

7D

2.2%

1Y

-37.1%

CEL

UK£1.58

Celadon Pharmaceuticals

7D

-6.0%

1Y

51.4%

AZN

UK£117.54

AstraZeneca

7D

0.8%

1Y

14.0%

DPH

UK£36.26

Dechra Pharmaceuticals

7D

8.6%

1Y

3.2%

HCM

UK£2.00

HUTCHMED (China)

7D

3.5%

1Y

8.7%

POLB

UK£0.084

Poolbeg Pharma

7D

7.7%

1Y

50.0%

APH

UK£0.60

Alliance Pharma

7D

-2.6%

1Y

-47.9%

INDV

UK£17.16

Indivior

7D

17.9%

1Y

8.5%

NFX

UK£0.0024

Nuformix

7D

-11.3%

1Y

-41.3%

SAR

UK£1.30

Sareum Holdings

7D

13.0%

1Y

-41.0%

KNB

UK£0.02

Kanabo Group

7D

-24.0%

1Y

-50.6%

EAH

UK£1.04

ECO Animal Health Group

7D

-7.6%

1Y

-13.3%

APOL

UK£0.0016

Apollon Formularies

7D

-8.6%

1Y

-91.1%